RYVESTA Trademark

Trademark Overview

On Thursday, September 20, 2012, a trademark application was filed for RYVESTA with the United States Patent and Trademark Office. The USPTO has given the RYVESTA trademark a serial number of 85734013. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 19, 2017. This trademark is owned by Novartis AG. The RYVESTA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceu...
ryvesta

General Information

Serial Number85734013
Word MarkRYVESTA
Filing DateThursday, September 20, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 19, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 18, 2014

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAnti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceuticals, namely, anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 24, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, June 19, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 19, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, November 20, 2016EXTENSION 5 GRANTED
Tuesday, November 8, 2016EXTENSION 5 FILED
Tuesday, November 8, 2016TEAS EXTENSION RECEIVED
Saturday, May 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 20, 2016EXTENSION 4 GRANTED
Thursday, May 5, 2016EXTENSION 4 FILED
Thursday, May 5, 2016TEAS EXTENSION RECEIVED
Thursday, December 31, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 30, 2015EXTENSION 3 GRANTED
Wednesday, November 11, 2015EXTENSION 3 FILED
Wednesday, November 11, 2015TEAS EXTENSION RECEIVED
Thursday, June 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 10, 2015EXTENSION 2 GRANTED
Sunday, May 10, 2015EXTENSION 2 FILED
Wednesday, June 10, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, May 10, 2015TEAS EXTENSION RECEIVED
Wednesday, November 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 10, 2014EXTENSION 1 GRANTED
Monday, November 10, 2014EXTENSION 1 FILED
Monday, November 10, 2014TEAS EXTENSION RECEIVED
Tuesday, May 13, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, February 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 10, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 3, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 27, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2014NON-FINAL ACTION E-MAILED
Monday, January 27, 2014NON-FINAL ACTION WRITTEN
Friday, January 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, July 23, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, July 23, 2013INQUIRY TO SUSPENSION E-MAILED
Tuesday, July 23, 2013SUSPENSION INQUIRY WRITTEN
Monday, July 22, 2013LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, July 22, 2013ASSIGNED TO LIE
Thursday, January 17, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 17, 2013LETTER OF SUSPENSION E-MAILED
Thursday, January 17, 2013SUSPENSION LETTER WRITTEN
Wednesday, January 16, 2013ASSIGNED TO EXAMINER
Monday, September 24, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 24, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

ryvesta preparations pharmaceutical treatment system diseases disorders pharmaceuticals hematology conditions transplantation